Introduction
SEM approach for discrete data
Stage 1 | Measurement model: observed discrete ordinal scores x are representations of underlying, continuous scores y* | ||
---|---|---|---|
What | How | Requirements | |
Step 1 | Test the assumption of underlying, bivariate normally distributed continuous scores for each pair of discrete ordinal variablesa
| The likelihood ratio (LR) test statistic can be used to test the hypothesis of underlying bivariate normal distributed continuous variables. The LR test is a test of exact fitb, the root-mean-square error of approximation (RMSEA) can be used to evaluate approximate fit, with the criterion that RMSEA values should not be larger than 0.1 [21] | Applicable only with three or more response categoriesc
|
Step 2 | Test the assumption of invariance of thresholds across occasions for each discrete ordinal variabled
| The difference in LR test statistics can be used to test the difference in exact fit [21]. The expected cross validation index (ECVI; [6]) can be used to test the difference in approximate fit, where a value that is significantly larger than zero indicates that the more restricted model (i.e., the model with equality constraints on the thresholds) has significantly worse approximate fit | Applicable only with 4 or more response categoriese
|
Step 3 | Investigate recalibration response shift as indicated by non-invariance of thresholds across occasions in the Stage 1 measurement model | To investigate whether the non-invariance of thresholds can be attributed to specific threshold parameters, the tenability of the equality restrictions across measurement occasions can be evaluated further. For example, by testing the invariance of individual thresholds. The LR test statistics can be used to test the difference in exact fit, and the ECVI difference can be used to test the difference in approximate fit | Applicable only with four or more response categoriesf
|
Step 4 | Assess differences in estimated means of the underlying variables (i.e., true change) across measurement occasions | The effect size can be estimated by d = \(\frac{{\hat{\mu }_{2} - \hat{\mu }_{1} }}{{\hat{\sigma }_{\text{diff}} }},\) where \(\hat{\mu }_{1}\) and \(\hat{\mu }_{2}\) are the estimated means of the underlying variables y* at occasions 1 and 2, and \(\hat{\sigma }_{\text{diff}}\) is given by \(\sqrt {\hat{\sigma }_{j1,j1}^{2} + \hat{\sigma }_{j2,j2}^{2} - 2\hat{\sigma }_{j2,j1} }\)), where variances \(\hat{\sigma }_{j1,j1}^{2}\) and \(\hat{\sigma }_{j2,j2}^{2} ,\) and covariance \(\hat{\sigma }_{j2,j1}\) are elements from the estimated covariance matrix \({\hat{\mathbf{\varSigma }}}_{{y^{*} }} ,\) as implied by the final model from Step 2 | Applicable only with two or more response categories |
Stage 2 | Measurement model: continuous scores y* are explained by a common factor model | ||
---|---|---|---|
What | How | Application | |
Step 1 | Test the common factor model by fitting it to the means, variances, and covariances of continuous scores y* obtained in Stage 1 | The Chi-square test can be used to evaluate exact goodness-of-fit, where a significant Chi-square indicates a significant difference between data and model. The RMSEA value can be used as a measure of approximate goodness-of-fit, where values below .08 indicate “reasonable” approximate fit and below .05 “close” approximate fit [7]. The hypothesis of close fit can be evaluated using the 90 % confidence intervals of the RMSEA value | Applicable only with three or more variablesg
|
Step 2 | Test the assumption of invariance of measurement parameters associated with response shift across measurement occasions | The Chi-square difference test can be used to test the difference in exact fit, where a significant Chi-square difference indicates that the no response shift model (with invariance restrictions imposed) has significantly worse fit as compared to the measurement model (without invariance restrictions). The ECVI difference can be used to test equivalence in approximate model fit | Applicable only with two or more variablesh
|
Step 3 | Investigate recalibration, reprioritization, and reconceptualization response shift as indicated by non-invariance of intercepts, factor loading values, and factor loading patterns across occasions in the Stage 2 measurement model | Improvement in model fit for each modification can be tested using the Chi-square difference test to evaluate differences in exact fit and the ECVI difference test to evaluate differences in approximate fit. In addition, the final model can be compared to the measurement model to test equivalence of exact and approximate fit | Applicable only with two or more variablesi
|
Step 4 | Assess differences in estimated means of the common factors (i.e., true change) across measurement occasions Decompose change in the means of the continuous variables y* across occasions into true change, recalibration response shift, and reprioritization or reconceptualization response shiftj
| The effect size of true change in the common factors between occasion 1 and 2 can be estimated by \(d \, = \frac{{\hat{\mu }_{2} - \hat{\mu }_{1} }}{{\hat{\sigma }_{\text{diff}} }},\) where \(\hat{\sigma }_{\text{diff}}\) is given by \(\sqrt {\hat{\varphi }_{r1,r1}^{2} + \hat{\varphi }_{r2,r2}^{2} - 2\hat{\varphi }_{r2,r1} } .\) The variances \(\hat{\varphi }_{r1,r1}^{2}\) and \(\hat{\varphi }_{r2,r2}^{2} ,\) and covariance \(\hat{\varphi }_{r2,r1}\) are elements from the estimated covariance matrix \({\hat{\mathbf{\varPhi }}}\) of the final model from Step 3 Change in the means of the observed variables can be decomposed as follows: \(\mu_{2} - \mu_{1} = (\tau_{2} - \tau_{1} ) + ((\varLambda_{2} - \varLambda_{1} )\kappa_{2} ) + \varLambda_{1} \kappa_{2} .\) Subsequently, effect sizes for modeled change \((\mu_{2} - \mu_{1} ),\) recalibration \((\tau_{2} - \tau_{1} ),\) reprioritization and reconceptualization \(((\varLambda_{2} - \varLambda_{1} )\kappa_{2} )\) and true change \((\varLambda_{1} \kappa_{2} )\) can be calculated using the standard deviation of change \(\hat{\sigma }_{\text{diff}}\) (as in Step 4 of Stage 1) | Applicable only with two or more variables |
Stage 1: Observed discrete ordinal scores x are representations of underlying, continuous scores y*
Step 1: Testing the underlying bivariate normality
Step 2: Testing invariance of thresholds across measurement occasions
Step 3: Investigating possible non-invariance of thresholds
Step 4: Assessment of true change
Stage 2: Continuous scores y* are explained by a common factor model
Step 1: Testing the measurement model
Step 2: Testing the invariance of measurement parameters across measurement occasions
Step 3: Investigating possible response shift effects
Step 4: Assessment of true change
Application
Patients
Measures
Variables | Selected study sample | Excluded sample |
---|---|---|
Mean (SD) | Mean (SD) | |
Age | 57.0 (12.1) | 60.0 (12.0) |
Karnofsky performance* | 78.4 (13.7) | 74.2 (13.0) |
N (%) |
N (%) | |
---|---|---|
Gender | ||
Men | 179 (41 %) | 25 (52 %) |
Women | 256 (59 %) | 23 (48 %) |
Education | ||
Primary school | 57 (13 %) | 7 (15 %) |
Lower secondary school | 186 (43 %) | 19 (40 %) |
Higher secondary school | 35 (8 %) | 3 (6 %) |
MBO | 81 (19 %) | 8 (17 %) |
HBO | 45 (10 %) | 5 (10 %) |
University | 29 (7 %) | 6 (13 %) |
Marital status | ||
Alone | 33 (8 %) | 5 (10 %) |
Married | 331 (77 %) | 37 (77 %) |
Divorced | 30 (7 %) | 2 (4 %) |
Widowed | 38 (9 %) | 4 (8 %) |
Tumor site | ||
Breast | 158 (36 %) | 12 (25 %) |
Colorectal | 105 (24 %) | 12 (25 %) |
Lung | 130 (30 %) | 20 (42 %) |
Other | 44 (10 %) | 4 (8 %) |
Treatment modality | ||
Radiotherapy | 220 (50 %) | 23 (48 %) |
Chemotherapy | 203 (47 %) | 25 (52 %) |
Combination therapy | 12 (3 %) | 0 (0 %) |
Stage of disease | ||
Local/loco-regional | 260 (60 %) | 23 (48 %) |
Metastatic | 171 (40 %) | 25 (52 %) |
Tumor response* | ||
Progressive | 44 (10 %) | 14 (48 %) |
Regressive | 79 (18 %) | 5 (17 %) |
No response | 311 (72 %) | 10 (35 %) |
Procedure
Results
Item | Time | Response categories | |||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | ||
Mental health (MH) | |||||||
24 Have you been a very nervous person? | Baseline | 14 (3 %) | 30 (7 %) | 55 (13 %) | 182 (42 %) | 91 (21 %) | 64 (15 %) |
Follow-up | 10 (2 %) | 16 (4 %) | 35 (8 %) | 154 (35 %) | 118 (27 %) | 103 (24 %) | |
25 Have you felt so down in the dumps that nothing could cheer you up? | Baseline | 7 (2 %) | 13 (3 %) | 24 (6 %) | 80 (18 %) | 112 (26 %) | 200 (6 %) |
Follow-up | 2 (0 %) | 7 (2 %) | 16 (4 %) | 76 (17 %) | 136 (31 %) | 199 (46 %) | |
26 Have you felt calm and peaceful? | Baseline | 23 (5 %) | 55 (13 %) | 100 (23 % | 69 (16 %) | 141 (32 %) | 48 (11 %) |
Follow-up | 20 (5 %) | 45 (10 %) | 114 (26 %) | 45 (10 %) | 167 (38 %) | 45 (10 %) | |
28 Have you felt downhearted and blue? | Baseline | 8 (2 %) | 17 (4 %) | 33 (8 %) | 145 (33 %) | 119 (27 %) | 114 (26 %) |
Follow-up | 7 (2 %) | 12 (3 %) | 22 (5 %) | 153 (35 %) | 120 (28 %) | 122 (28 %) | |
30 Have you been a happy person? | Baseline | 20 (5 %) | 22 (5 %) | 85 (20 %) | 48 (11 %) | 135 (31 %) | 126 (29 %) |
Follow-up | 21 (5 %) | 29 (7 %) | 81 (19 %) | 52 (12 %) | 154 (35 %) | 99 (23 %) | |
General physical health (GH) | |||||||
1 In general, would you say your health is…? | Baseline | 50 (12 %) | 153 (35 %) | 162 (37 %) | 40 (9 %) | 31 (7 %) | |
Follow-up | 32 (7 %) | 179 (41 %) | 174 (40 %) | 40 (9 %) | 11 (3 %) | ||
33 I seem to get sick a little easier than other people | Baseline | 24 (6 %) | 29 (7 %) | 118 (27 %) | 60 (14 %) | 205 (47 %) | |
Follow-up | 20 (4 %) | 41 (9 %) | 131 (30 %) | 59 (14 %) | 185 (42 %) | ||
34 I am as health as anybody I know | Baseline | 94 (22 %) | 100 (23 %) | 102 (23 %) | 76 (17 %) | 64 (15 %) | |
Follow-up | 99 (23 %) | 91 (21 %) | 125 (29 %) | 73 (17 %) | 48 (11 %) | ||
35 I expect my health to get worse | Baseline | 46 (11 %) | 56 (13 %) | 172 (39 %) | 58 (13 %) | 104 (24 %) | |
Follow-up | 35 (8 %) | 47 (11 %) | 197 (45 %) | 56 (13 %) | 101 (23 %) | ||
36 My health is excellent | Baseline | 130 (30 %) | 71 (16 %) | 80 (18 %) | 101 (23 %) | 54 (12 %) | |
Follow-up | 131 (30 %) | 87 (20 %) | 71 (16 %) | 112 (26 %) | 35 (8 %) | ||
Physical functioning (PF) | |||||||
3 Vigorous activities | Baseline | 274 (63 %) | 138 (32 %) | 25 (6 %) | |||
Follow-up | 289 (66 %) | 120 (27 %) | 28 (6 %) | ||||
4 Moderate activities | Baseline | 142 (33 %) | 181 (41 %) | 114 (26 %) | |||
Follow-up | 135 (31 %) | 185 (42 %) | 117 (27 %) | ||||
5 Lifting or carrying groceries | Baseline | 128 (29 %) | 184 (42 %) | 125 (29 %) | |||
Follow-up | 114 (24 %) | 161 (37 %) | 172 (39 %) | ||||
6 Climbing several flights of stairs | Baseline | 85 (19 %) | 149 (34 %) | 203 (46 %) | |||
Follow-up | 104 (24 %) | 161 (37 %) | 172 (40 %) | ||||
7 Climbing one flight of stairs | Baseline | 31 (7 %) | 117 (27 %) | 289 (66 %) | |||
Follow-up | 30 (7 %) | 128 (29 %) | 279 (64 %) | ||||
8 Bending, kneeling, or stooping | Baseline | 57 (13 %) | 151 (35 %) | 229 (52 %) | |||
Follow-up | 58 (13 %) | 150 (34 %) | 229 (52 %) | ||||
9 Walking more than a mile | Baseline | 115 (26 %) | 129 (30 %) | 193 (44 %) | |||
Follow-up | 126 (29 %) | 127 (29 %) | 184 (42 %) | ||||
10 Walking several blocks | Baseline | 54 (12 %) | 95 (22 %) | 288 (66 %) | |||
Follow-up | 68 (16 %) | 97 (22 %) | 272 (62 %) | ||||
11 Walking one block | Baseline | 35 (8 %) | 75 (17 %) | 327 (75 %) | |||
Follow-up | 41 (9 %) | 73 (17 %) | 323 (74 %) | ||||
12 Bathing or dressing yourself | Baseline | 11 (3 %) | 63 (14 %) | 363 (83 %) | |||
Follow-up | 19 (4 %) | 47 (11 %) | 371 (85 %) | ||||
Role limitations due to physical health (RP) | |||||||
13 Did you cut down on the amount of time you spent on work or other activities? | Baseline | 306 (70 %) | 131 (30 %) | ||||
Follow-up | 290 (66 %) | 147 (34 %) | |||||
14 Did you accomplished less than you would like? | Baseline | 259 (59 %) | 178 (41 %) | ||||
Follow-up | 254 (58 %) | 183 (42 %) | |||||
15 Were you limited in the kind of work or other activities? | Baseline | 293 (67 %) | 144 (33 %) | ||||
Follow-up | 303 (69 %) | 134 (31 %) | |||||
16 Did you have difficulty performing the work or other activities? | Baseline | 273 (62 %) | 164 (38 %) | ||||
Follow-up | 294 (67 %) | 143 (33 %) | |||||
Bodily pain (BP) | |||||||
21 How much bodily pain have you had? | Baseline | 3 (1 %) | 20 (5 %) | 97 (22 %) | 78 (18 %) | 88 (20 %) | 151 (35 %) |
Follow-up | 7 (2 %) | 21 (5 %) | 93 (21 %) | 95 (22 %) | 81 (19 %) | 140 (32 %) | |
22 How much did pain interfere with your normal work? | Baseline | 17 (4 %) | 27 (6 %) | 89 (20 %) | 120 (28 %) | 184 (42 %) | |
Follow-up | 13 (3 %) | 23 (5 %) | 49 (11 %) | 125 (29 %) | 227 (52 %) | ||
Social functioning (SF) | |||||||
20 To what extent have your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | Baseline | 9 (2 %) | 25 (6 %) | 43 (10 %) | 131 (30 %) | 229 (52 %) | |
Follow-up | 13 (3 %) | 23 (5 %) | 49 (11 %) | 125 (29 %) | 227 (52 %) | ||
32 How much of the time has your physical health or emotional problems interfered with your social activities? | Baseline | 24 (5 %) | 36 (8 %) | 145 (33 %) | 68 (16 %) | 164 (38 %) | |
Follow-up | 34 (8 %) | 41 (9 %) | 132 (30 %) | 74 (17 %) | 156 (36 %) | ||
Role limitations due to emotional problems (RE) | |||||||
17 Did you cut down on the amount of time you spent on work or other activities? | Baseline | 195 (45 %) | 242 (55 %) | ||||
Follow-up | 175 (40 %) | 262 (60 %) | |||||
18 Did you accomplished less than you would like? | Baseline | 190 (44 %) | 247 (57 %) | ||||
Follow-up | 176 (40 %) | 261 (60 %) | |||||
19 Did you do work or other activities less carefully than usual? | Baseline | 153 (35 %) | 284 (65 %) | ||||
Follow-up | 147 (34 %) | 290 (66 %) | |||||
Vitality (VT) | |||||||
23 Did you feel full of pep? | Baseline | 16 (4 %) | 32 (7 %) | 105 (24 %) | 58 (13 %) | 145 (33 %) | 81 (19 %) |
Follow-up | 21 (5 %) | 42 (10 %) | 104 (24 %) | 60 (14 %) | 155 (35 %) | 55 (13) | |
27 Did you have a lot of energy? | Baseline | 26 (6 %) | 73 (17 %) | 133 (30 %) | 56 (13 %) | 94 (22 %) | 55 (13 %) |
Follow-up | 35 (8 %) | 96 (22 %) | 134 (31 %) | 53 (12 %) | 83 (19 %) | 36 (8 %) | |
29 Did you feel worn out? | Baseline | 13 (3 %) | 19 (4 %) | 48 (11 %) | 135 (90 %) | 90 (2 %) | 132 (30 %) |
Follow-up | 11 (3 %) | 28 (6 %) | 56 (13 %) | 147 (34 %) | 100 (23 %) | 95 (22 %) | |
31 Did you feel tired? | Baseline | 29 (7 %) | 52 (12 %) | 77 (18 %) | 166 (38 %) | 61 (14 %) | 52 (12 %) |
Follow-up | 37 (8 %) | 53 (12 %) | 106 (24 %) | 155 (35 %) | 56 (13 %) | 20 (7 %) | |
Health comparison (HC) | |||||||
2 Compared to 1 year ago, how would you rate your health in general now? | Baseline | 32 (7 %) | 83 (19 %) | 272 (62 %) | 43 (10 %) | 7 (2 %) | |
Follow-up | 34 (8 %) | 69 (16 %) | 243 (56 %) | 78 (18 %) | 13 (3 %) |
Step 1 | Step 2 | Step 3 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVN |
df
| Chisqdiff
|
p
| Thresholds | Meansa
| SDsa
|
\(\rho\)
| |||||||
1 | 2 | 3 | 4 | 5 | Pre | Post | Pre | Post | ||||||
MH | ||||||||||||||
24 | ✓ | 3 | 4.14 | 0.25 | −1.96 | −1.41 | −0.90 | 0.19 | 0.85 | 3.23 | 3.83 | 1.74 | 1.85 | 0.59 |
25 | ✓ | 3 | 0.59 | 0.90 | −2.34 | −1.84 | −1.14 | −0.63 | 0.10 | 4.70 | 4.75 | 2.19 | 1.84 | 0.61 |
26b
| ✓ | 3 | 15.6 | <0.01 | ||||||||||
26pre
| −1.62 | −0.92 | −0.23 | 0.16 | 1.20 | |||||||||
26post
| −1.69 | −1.03 | −0.23 | 0.03 | 1.24 | |||||||||
28 | ✓ | 3 | 5.52 | 0.14 | −2.16 | −1.64 | −1.16 | −0.13 | 0.60 | 4.09 | 4.24 | 1.96 | 1.90 | 0.53 |
30 | ✓ | 3 | 5.41 | 0.14 | −1.68 | −1.28 | −0.51 | −0.21 | 0.62 | 4.40 | 4.12 | 2.61 | 2.47 | 0.64 |
GH | ||||||||||||||
1 | ✓ | 2 | 3.61 | 0.16 | −1.31 | −0.07 | 1.10 | 1.65 | 1.08 | 1.04 | 0.90 | 0.71 | 0.62 | |
33 | ✓ | 2 | 3.63 | 0.16 | −1.62 | −1.17 | −0.23 | 0.14 | 3.72 | 3.40 | 2.32 | 2.05 | 0.55 | |
34 | ✓ | 2 | 4.88 | 0.09 | −0.77 | −0.10 | 0.52 | 1.13 | 1.19 | 1.11 | 1.56 | 1.41 | 0.49 | |
35 | ✓ | 2 | 2.25 | 0.32 | −1.34 | −0.79 | 0.31 | 0.72 | 2.39 | 2.46 | 1.91 | 1.72 | 0.56 | |
36 | ✓ | 2 | 4.91 | 0.09 | −0.53 | −0.07 | 0.44 | 1.26 | 1.22 | 1.07 | 2.29 | 2.02 | 0.62 | |
PF | ||||||||||||||
3 | ✓ | n/a | 0.37 | 1.55 | −0.26 | −0.38 | 0.80 | 0.91 | 0.60 | |||||
4 | ✓ | n/a | −0.48 | 0.63 | 0.42 | 0.45 | 0.91 | 0.89 | 0.65 | |||||
5 | ✓ | n/a | −0.59 | 0.59 | 0.49 | 0.51 | 0.90 | 0.79 | 0.72 | |||||
6 | ✓ | n/a | −0.79 | 0.18 | 0.91 | 0.73 | 1.05 | 1.02 | 0.74 | |||||
7 | ✓ | n/a | −1.48 | −0.39 | 1.40 | 1.31 | 0.95 | 0.88 | 0.71 | |||||
8 | ✓ | n/a | −1.12 | −0.06 | 1.06 | 1.06 | 0.94 | 0.95 | 0.73 | |||||
9 | ✓ | n/a | −0.60 | 0.17 | 0.81 | 0.74 | 1.28 | 1.32 | 0.74 | |||||
10 | ✓ | n/a | −1.08 | −0.36 | 1.55 | 1.45 | 1.34 | 1.43 | 0.70 | |||||
11 | ✓ | n/a | −1.36 | −0.65 | 1.91 | 1.95 | 1.36 | 1.48 | 0.67 | |||||
12 | ✓ | n/a | −1.78 | −0.98 | 1.96 | 2.52 | 1.00 | 1.47 | 0.66 | |||||
RP | ||||||||||||||
13 | n/a | n/a | 0.47 | −0.53 | −0.42 | 1.00 | 1.00 | 0.52 | ||||||
14 | n/a | n/a | 0.22 | −0.23 | −0.21 | 1.00 | 1.00 | 0.51 | ||||||
15 | n/a | n/a | 0.47 | −0.44 | −0.51 | 1.00 | 1.00 | 0.55 | ||||||
16 | n/a | n/a | 0.38 | −0.32 | −0.45 | 1.00 | 1.00 | 0.49 | ||||||
BP | ||||||||||||||
21 | ✓ | 3 | 9.77 | 0.02 | −2.34 | −1.53 | −0.55 | −0.84 | 0.41 | 2.92 | 2.85 | 1.18 | 1.28 | 0.55 |
22 | ✓ | 2 | 0.58 | 0.75 | −1.74 | −1.23 | −0.56 | 0.11 | 3.63 | 2.85 | 2.06 | 1.28 | 0.51 | |
SF | ||||||||||||||
20 | ✓ | 2 | 1.48 | 0.48 | −1.98 | −1.38 | −0.90 | −0.06 | 3.28 | 3.28 | 1.61 | 1.71 | 0.42 | |
32 | ✓ | 2 | 3.09 | 0.21 | −1.51 | −1.02 | −0.05 | 0.33 | 3.16 | 3.06 | 1.98 | 2.15 | 0.48 | |
RE | ||||||||||||||
17 | n/a | n/a | −0.19 | 0.14 | 0.25 | 1.00 | 1.00 | 0.52 | ||||||
18 | n/a | n/a | −0.21 | 0.16 | 0.25 | 1.00 | 1.00 | 0.60 | ||||||
19 | n/a | n/a | −0.40 | 0.39 | 0.42 | 1.00 | 1.00 | 0.47 | ||||||
VT | ||||||||||||||
23 | ✓ | 3 | 6.67 | 0.08 | −1.74 | −1.17 | −0.31 | 0.04 | 0.99 | 3.18 | 2.90 | 1.77 | 1.72 | 0.56 |
27 | ✓ | 3 | 1.05 | 0.79 | −1.48 | −0.66 | 0.18 | 0.52 | 1.26 | 1.93 | 1.68 | 1.24 | 1.21 | 0.58 |
29 | ✓ | 3 | 3.46 | 0.33 | −1.89 | −1.43 | −0.86 | 0.07 | 0.64 | 4.36 | 3.95 | 2.31 | 2.08 | 0.45 |
31 | ✓ | 3 | 5.86 | 0.12 | −1.46 | −0.83 | −0.27 | 0.77 | 1.32 | 2.47 | 2.16 | 1.64 | 1.64 | 0.52 |
HC | ||||||||||||||
2 | ✓ | 2 | 6.96 | 0.03 | −0.68 | 1.07 | 1.96 | 1.77 | 1.97 | 1.22 | 1.35 | 0.03 |
Model |
df
|
χ
2
| RMSEA [90 % CI] | ECVI [90 % CI] | Compared to |
df
diff
| CHISQdiff
| ECVIdiff [90 % CI] |
---|---|---|---|---|---|---|---|---|
Mental health (MH) | ||||||||
1a Measurement model | 25 | 61.559 | 0.058 [0.040; 0.076] | 0.279 [0.235; 0.341] | ||||
1b No response shift model | 31 | 158.28 | 0.097 [0.082; 0.112] | 0.386 [0.304; 0.485] | Model 1a | 6 | 96.72 | 0.194 [0.123; 0.276] |
1c Response shift model | 28 | 62.979 | 0.054 [0.036; 0.071] | 0.268 [0.224; 0.330] | Model 1a | 3 | 1.320 | −0.011 [−0.007; 0.003] |
General physical health (GH) | ||||||||
2a Measurement model | 29 | 61.286 | 0.047 [0.031; 0.063] | 0.162 [0.115; 0.227] | ||||
2b No response shift model | 37 | 72.601 | 0.051 [0.033; 0.068] | 0.173 [0.130; 0.233] | Model 2a | 8 | 11.32 | −0.011 [−0.018; 0.019] |
Physical functioning (PF)a
| ||||||||
3a Measurement Model | 151 | 339.06 | 0.053 [0.046; 0.061] | 1.048 [0.935; 1.180] | ||||
3b No response shift model | 169 | 477.64 | 0.065 [0.058; 0.072] | 1.284 [1.143; 1.442] | Model 3a | 18 | 380.7 | 0.791 [0.654; 0945] |
3c Response shift model | 166 | 374.98 | 0.054 [0.047; 0.061] | 1.062 [0.942; 1.200] | Model 3a | 15 | 46.75 | 0.038 [−0.001; 0.095] |
Role limitations due to physical health (RP) | ||||||||
4a Measurement model | 15 | 29.727 | 0.048 [0.021; 0.072] | 0.165 [0.138; 0.210] | ||||
4b No response shift model | 18 | 72.543 | 0.083 [0.064; 0.104] | 0.249 [0.120; 0.318] | ||||
4c Response shift model | 17 | 51.313 | 0.068 [0.047; 0.090] | 0.205 [0.164; 0.263] | ||||
Bodily pain (BP) | ||||||||
5a Measurement model | 1 | 1.798 | 0.043 [0; 0.143] | 0.045 [0.044; 0.064] | ||||
5b No response shift model | 3 | 39.766 | 0.168 [0.124; 0.216] | 0.123 [0.085; 0.179] | Model 5a | 2 | 37.968 | 0.078 [0.040; 0.133] |
5c Response Shift Model | 2 | 5.941 | 0.067 [0; 0.133] | 0.073 [0.038; 0.125] | Model 5a | 1 | 4.143 | 0.005 [−0.002; 0.029] |
Social functioning (SF) | ||||||||
6a Measurement Model | 1 | 0.143 | 0 [0; 0.092] | 0.042 [0.044; 0.052] | ||||
6b No response shift model | 2 | 1.303 | 0 [0; 0.084] | 0.040 [0.041; 0.055] | Model 6a | 1 | 1.16 | −0.002 [−0.002; 0.015] |
Role limitations due to emotional problems (RE) | ||||||||
7a Measurement model | 5 | 13.022 | 0.061 [0.021; 0.102] | 0.103 [0.087; 0.137] | ||||
7b No response shift model | 7 | 17.834 | 0.060 [0.026; 0.095] | 0.105 [0.085; 0.143] | ||||
Vitality (VT) | ||||||||
8a Measurement model | 11 | 4.7300 | 0 [0; 0.009] | 0.126 [0.140; 0.141] | ||||
8b No response shift model | 17 | 12.326 | 0 [0; 0.030] | 0.116 [0.126; 0.141] | Model 8a | 6 | 7.596 | −0.010 [−0.014; 0.016] |
Item | Stage 1 | Stage 2 | |||
---|---|---|---|---|---|
Observed change in variables x
a
| True change in underlying variables y* | Modeled change in variables y* | Response shift change | True change | |
Mental health (MH) | |||||
24 | 0.33** | 0.37** | 0.36** | 0.30c**/0.01d
| 0.04 |
25 | 0.12* | 0.03 | 0.06 | 0.06 | |
26b
| 0.06 | ||||
28 | 0.08 | 0.08 | 0.05 | 0.05 | |
30 | −0.08 | −0.13* | −0.13* | −0.16c** | 0.03 |
General physical health (GH) | |||||
1 | −0.08 | −0.05 | −0.08 | −0.08 | |
33 | −0.08 | −0.15* | −0.04 | −0.04 | |
34 | −0.06 | −0.06 | −0.07 | −0.07 | |
35 | 0.05 | 0.04 | −0.05 | −0.05 | |
36 | −0.08 | −0.08 | −0.11* | −0.11* | |
Physical functioning (PF) | |||||
3 | −0.04 | −0.15* | −0.04 | −0.00d
| −0.04 |
4 | 0.03 | 0.04 | −0.04 | −0.04 | |
5 | 0.02 | 0.02 | −0.04 | −0.04 | |
6 | −0.17** | −0.24** | −0.05 | −0.05 | |
7 | −0.04 | −0.12* | −0.05 | −0.05 | |
8 | 0.00 | 0.00 | −0.05 | −0.05 | |
9 | −0.06 | −0.08 | −0.05 | −0.05 | |
10 | −0.10* | −0.10* | −0.06 | −0.06 | |
11 | −0.04 | 0.03 | −0.05 | −0.05 | |
12 | 0.00 | 0.51** | 0.46** | 0.51c**/−0.02d
| −0.03 |
Role limitations due to physical health (RP) | |||||
13 | 0.07 | 0.11* | 0.02 | 0.08c
| −0.06 |
14 | 0.02 | 0.03 | −0.06 | −0.06 | |
15 | −0.04 | −0.07 | −0.07 | −0.07 | |
16 | −0.09 | −0.13* | −0.06 | −0.06 | |
Bodily pain (BP) | |||||
21 | −0.07 | −0.06 | −0.06 | −0.23** | 0.17** |
22 | 0.08 | 0.16** | 0.16** | 0.16** | |
Social functioning (SF) | |||||
20 | −0.03 | 0.00 | −0.04 | −0.04 | |
32 | −0.06 | −0.05 | −0.03 | −0.03 | |
Role limitations due to emotional problems (RE) | |||||
17 | 0.08 | 0.12* | 0.09 | 0.09 | |
18 | 0.06 | 0.09 | 0.10* | 0.10* | |
19 | 0.02 | 0.04 | 0.08 | 0.08 | |
Vitality (VT) | |||||
23 | −0.13* | −0.17** | −0.19** | −0.19** | |
27 | −0.20** | −0.22** | −0.27** | −0.27** | |
29 | −0.14* | −0.18** | −0.16** | −0.16** | |
31 | −0.18** | −0.20** | −0.20** | −0.20** | |
Health comparison (HC) | |||||
2 | 0.11* | 0.11* |